Diagnosis and management of chronic daily headache

Seminars in Neurology

Volumn 30, Issue 2, 2010, Pages 154-166

  Garza, Ivan ^a   Schwedt, Todd J ^b  

^a MAYO CLINIC   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Chronic; Daily; Headache; Hemicrania; Migraine

Indexed keywords

AMITRIPTYLINE; BOTULINUM TOXIN; DEXAMETHASONE; DICHLORALPHENAZONE; DIHYDROERGOTAMINE; ETIRACETAM; FLUOXETINE; GABAPENTIN; HYDROCORTISONE; INDOMETACIN; ISOMETHEPTENE; MEMANTINE; METHYLPREDNISOLONE; METOCLOPRAMIDE; MIRTAZAPINE; NAPROXEN; NORTRIPTYLINE; PARACETAMOL; PLACEBO; PREDNISONE; PROCHLORPERAZINE; PROTRIPTYLINE; TIZANIDINE; TOPIRAMATE; VALPROATE SEMISODIUM; VALPROIC ACID;

ALOPECIA; AREA UNDER THE CURVE; ASTHENIA; BEHAVIOR THERAPY; CHRONIC DAILY HEADACHE; CHRONIC TENSION HEADACHE; CLINICAL TRIAL; CLOSED ANGLE GLAUCOMA; COGNITIVE THERAPY; CONSTIPATION; COST BENEFIT ANALYSIS; DIZZINESS; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG INDUCED HEADACHE; DRUG MECHANISM; EDEMA; FATIGUE; HEALTH CARE COST; HEART ARRHYTHMIA; HEMICRANIA CONTINUA; HEPATITIS; HUMAN; HYPERTHERMIA; INSOMNIA; LIVER FAILURE; LOADING DRUG DOSE; METABOLIC ACIDOSIS; MORNING DOSAGE; NAUSEA; NEUTROPENIA; NEW DAILY PERSISTENT HEADACHE; PAIN ASSESSMENT; PANCREATITIS; PARESTHESIA; PATIENT CARE; PATIENT EDUCATION; PRIORITY JOURNAL; QT PROLONGATION; QUALITY OF LIFE; REVIEW; SECONDARY HEADACHE; SEDATION; SIDE EFFECT; SOMNOLENCE; TENSION HEADACHE; THROMBOCYTOPENIA; TRANSFORMED MIGRAINE; TREATMENT OUTCOME; TREMOR; WEIGHT CHANGE; WEIGHT GAIN; WEIGHT REDUCTION; XEROSTOMIA;

ANALGESIA; ANTICONVULSANTS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; BOTULINUM TOXINS; DIAGNOSIS, DIFFERENTIAL; DRUG ADMINISTRATION SCHEDULE; HEADACHE DISORDERS; HEADACHE DISORDERS, SECONDARY; HUMANS; NEUROPHARMACOLOGY; RECURRENCE; SEROTONIN AGENTS;

EID: 77950465858     PISSN: 02718235     EISSN: 10989021     Source Type: Journal    
DOI: 10.1055/s-0030-1249224     Document Type: Review

References (139)

1. Scher A I., Stewart W F., Liberman J, Lipton R B. Prevalence of frequent headache in a population sample. Headache 1998 38 (7) 497-506
2. Lu S R., Fuh J L., Chen W T., Juang K D., Wang S J. Chronic daily headache in Taipei, Taiwan: prevalence, follow-up and outcome predictors. Cephalalgia 2001 21 (10) 980-986
3. Wang S J., Fuh J L., Lu S R. et al. Chronic daily headache in Chinese elderly: prevalence, risk factors, and biannual follow-up. Neurology 2000 54 (2) 314-319
4. Stewart W F., Ricci J A., Chee E, Morganstein D, Lipton R. Lost productive time and cost due to common pain conditions in the US workforce. JAMA 2003 290 (18) 2443-2454
5. Lipton R B., Stewart W F., Scher A I. Epidemiology and economic impact of migraine. Curr Med Res Opin 2001 17 (Suppl 1) s4-s12
6. Scher A I., Midgette L A., Lipton R B. Risk factors for headache chronification. Headache 2008 48 (1) 16-25
7. Scher A I., Stewart W F., Buse D, Krantz D S., Lipton R B. Major life changes before and after the onset of chronic daily headache: a population-based study. Cephalalgia 2008 28 (8) 868-876
8. Scher A I., Stewart W F., Lipton R B. Caffeine as a risk factor for chronic daily headache: a population-based study. Neurology 2004 63 (11) 2022-2027
9. Scher A I., Stewart W F., Ricci J A., Lipton R B. Factors associated with the onset and remission of chronic daily headache in a population-based study. Pain 2003 106 (1-2) 81-89
10. Castillo J, Muoz P, Guitera V, Pascual J. Kaplan Award 1998. Epidemiology of chronic daily headache in the general population. Headache 1999 39 (3) 190-196
11. Guitera V, Muoz P, Castillo J, Pascual J. Quality of life in chronic daily headache: a study in a general population. Neurology 2002 58 (7) 1062-1065
12. D'Amico D, Usai S, Grazzi L et al. Quality of life and disability in primary chronic daily headaches. Neurol Sci 2003 24 (Suppl 2) S97-S100
13. Harwood R H., Sayer A A., Hirschfeld M. Current and future worldwide prevalence of dependency, its relationship to total population, and dependency ratios. Bull World Health Organ 2004 82 (4) 251-258
14. Munakata J, Hazard E, Serrano D et al. Economic burden of transformed migraine: results from the American Migraine Prevalence and Prevention (AMPP) Study. Headache 2009 49 (4) 498-508
15. Katsarava Z, Schneeweiss S, Kurth T et al. Incidence and predictors for chronicity of headache in patients with episodic migraine. Neurology 2004 62 (5) 788-790
16. Lipton R B. Tracing transformation: chronic migration classification, progression, and epidemiology. Neurology 2009 72 (5 Suppl) S3-S7
17. Sarchielli P, Alberti A, Floridi A, Gallai V. Levels of nerve growth factor in cerebrospinal fluid of chronic daily headache patients. Neurology 2001 57 (1) 132-134
18. Schwedt T J., Dodick D W. Advanced neuroimaging of migraine. Lancet Neurol 2009 8 (6) 560-568
19. Welch K M., Nagesh V, Aurora S K., Gelman N. Periaqueductal gray matter dysfunction in migraine: cause or the burden of illness? Headache 2001 41 (7) 629-637
20. Kruit M C., Launer L J., Overbosch J, van Buchem M A., Ferrari M D. Iron accumulation in deep brain nuclei in migraine: a population-based magnetic resonance imaging study. Cephalalgia 2009 29 (3) 351-359
21. Schmitz N, Admiraal-Behloul F, Arkink E B. et al. Attack frequency and disease duration as indicators for brain damage in migraine. Headache 2008 48 (7) 1044-1055
22. Valfr W, Rainero I, Bergui M, Pinessi L. Voxel-based morphometry reveals gray matter abnormalities in migraine. Headache 2008 48 (1) 109-117
23. Rocca M A., Ceccarelli A, Falini A et al. Brain gray matter changes in migraine patients with T2-visible lesions: a 3-T MRI study. Stroke 2006 37 (7) 1765-1770
24. Schmitz N, Arkink E B., Mulder M et al. Frontal lobe structure and executive function in migraine patients. Neurosci Lett 2008 440 (2) 92-96
25. Granziera C, DaSilva A F., Snyder J, Tuch D S., Hadjikhani N. Anatomical alterations of the visual motion processing network in migraine with and without aura. PLoS Med 2006 3 (10) e402
26. Ashkenazi A, Mushtaq A, Yang I, Oshinsky M L. Ictal and interictal phonophobia in migraine-a quantitative controlled study. Cephalalgia 2009 29 (10) 1042-1048
27. Olesen J, Bousser M G., Diener H C. et al, Headache Classification Committee. New appendix criteria open for a broader concept of chronic migraine. Cephalalgia 2006 26 (6) 742-746
28. Silberstein S D., Lipton R B., Dodick D W. et al, Topiramate Chronic Migraine Study Group. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial. Headache 2007 47 (2) 170-180
29. Diener H C., Bussone G, Van Oene J C., Lahaye M, Schwalen S, Goadsby P J., TOPMAT-MIG-201(TOP-CHROME) Study Group. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study. Cephalalgia 2007 27 (7) 814-823
30. Spira P J., Beran R G., Australian Gabapentin Chronic Daily Headache Group. Gabapentin in the prophylaxis of chronic daily headache: a randomized, placebo-controlled study. Neurology 2003 61 (12) 1753-1759
31. Saper J R., Lake A E. III, Cantrell D T., Winner P K., White J R. Chronic daily headache prophylaxis with tizanidine: a double-blind, placebo-controlled, multicenter outcome study. Headache 2002 42 (6) 470-482
32. Saper J R., Silberstein S D., Lake A E. III, Winters M E. Double-blind trial of fluoxetine: chronic daily headache and migraine. Headache 1994 34 (9) 497-502
33. Krymchantowski A V., Silva M T., Barbosa J S., Alves L A. Amitriptyline versus amitriptyline combined with fluoxetine in the preventative treatment of transformed migraine: a double-blind study. Headache 2002 42 (6) 510-514
34. Rapoport A M., Sheftell F D., Tepper S J., Bigal M. Levetiracetam in the preventive treatment of transformed migraine. Curr Ther Res 2005 66 212-221
35. Mathew N T., Ali S. Valproate in the treatment of persistent chronic daily headache. An open label study. Headache 1991 31 (2) 71-74
36. Freitag F G., Diamond S, Diamond M L., Urban G J. Divalproex in the long-term treatment of chronic daily headache. Headache 2001 41 (3) 271-278 (Pubitemid 32242612)
37. Naumann M, So Y, Argoff C E. et al, Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Assessment: Botulinum neurotoxin in the treatment of autonomic disorders and pain (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2008 70 (19) 1707-1714 (Pubitemid 351644139)
38. Spengos K, Theleritis C, Paparrigopoulos T. Memantine and NMDA antagonism for chronic migraine: a potentially novel therapeutic approach? Headache 2008 48 (2) 284-286
39. Bigal M, Rapoport A, Sheftell F, Tepper D, Tepper S. Memantine in the preventive treatment of refractory migraine. Headache 2008 48 (9) 1337-1342
40. Ciancarelli I, Tozzi-Ciancarelli M G., Spacca G, Di Massimo C, Carolei A. Relationship between biofeedback and oxidative stress in patients with chronic migraine. Cephalalgia 2007 27 (10) 1136-1141
41. Martin P R., Forsyth M R., Reece J. Cognitive-behavioral therapy versus temporal pulse amplitude biofeedback training for recurrent headache. Behav Ther 2007 38 (4) 350-363
42. Lockett D M., Campbell J F. The effects of aerobic exercise on migraine. Headache 1992 32 (1) 50-54
43. Marcus D A., Scharff L, Mercer S, Turk D C. Nonpharmacological treatment for migraine: incremental utility of physical therapy with relaxation and thermal biofeedback. Cephalalgia 1998 18 (5) 266-272, discussion 242
44. Seok J I., Cho H I., Chung C S. From transformed migraine to episodic migraine: reversion factors. Headache 2006 46 (7) 1186-1190
45. Schwartz B S., Stewart W F., Simon D, Lipton R B. Epidemiology of tension-type headache. JAMA 1998 279 (5) 381-383
46. Lavados P M., Tenhamm E. Epidemiology of tension-type headache in Santiago, Chile: a prevalence study. Cephalalgia 1998 18 (8) 552-558
47. Russell M B., Levi N, Saltyte-Benth J, Fenger K. Tension-type headache in adolescents and adults: a population based study of 33,764 twins. Eur J Epidemiol 2006 21 (2) 153-160
48. Bendtsen L, Jensen R. Tension-type headache: the most common, but also the most neglected, headache disorder. Curr Opin Neurol 2006 19 (3) 305-309
49. Juang K D., Wang S J., Fuh J L., Lu S R., Su T P. Comorbidity of depressive and anxiety disorders in chronic daily headache and its subtypes. Headache 2000 40 (10) 818-823
50. Fumal A S. Chronic tension-type headache In: Goadsby PJ, Dodick DW Chronic Daily Headache for Clinicians. 1st Ed. Hamilton, Ontario BC Decker Inc 2005 57-64
51. Mathew N T. Tension-type headache. Curr Neurol Neurosci Rep 2006 6 (2) 100-105
52. Bendtsen L, Jensen R, Olesen J. Decreased pain detection and tolerance thresholds in chronic tension-type headache. Arch Neurol 1996 53 (4) 373-376
53. Buchgreitz L, Egsgaard L L., Jensen R, Arendt-Nielsen L, Bendtsen L. Abnormal pain processing in chronic tension-type headache: a high-density EEG brain mapping study. Brain 2008 131 (Pt 12) 3232-3238
54. Pielsticker A, Haag G, Zaudig M, Lautenbacher S. Impairment of pain inhibition in chronic tension-type headache. Pain 2005 118 (1-2) 215-223
55. Schmidt-Wilcke T, Leinisch E, Straube A et al. Gray matter decrease in patients with chronic tension type headache. Neurology 2005 65 (9) 1483-1486
56. Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders, 2nd Edition. Cephalalgia 2004 24 (Suppl 1) 1-160
57. Jensen R, Becker W J. Symptomatology of chronic tension-type headaches In: Olesen J, Ramadan NM, Tfelt-Hansen P, Welch KMA The Headaches. 3rd ed. Philadelphia Lippincott Williams and Wilkins 2006 693-699
58. Bigal M E., Lipton R B. Tension-type headache: classification and diagnosis. Curr Pain Headache Rep 2005 9 (6) 423-429
59. Lenaerts M E. Pharmacoprophylaxis of tension-type headache. Curr Pain Headache Rep 2005 9 (6) 442-447
60. Bendtsen L, Jensen R, Olesen J. A non-selective (amitriptyline), but not a selective (citalopram), serotonin reuptake inhibitor is effective in the prophylactic treatment of chronic tension-type headache. J Neurol Neurosurg Psychiatry 1996 61 (3) 285-290
61. Bendtsen L, Jensen R. Mirtazapine is effective in the prophylactic treatment of chronic tension-type headache. Neurology 2004 62 (10) 1706-1711
62. Garza I, Swanson J W. Prophylaxis of migraine. Neuropsychiatr Dis Treat 2006 2 (3) 281-291
63. Holroyd K A., O'Donnell F J., Stensland M, Lipchik G L., Cordingley G E., Carlson B W. Management of chronic tension-type headache with tricyclic antidepressant medication, stress management therapy, and their combination: a randomized controlled trial. JAMA 2001 285 (17) 2208-2215 (Pubitemid 32416766)
64. Cohen G L. Protriptyline, chronic tension-type headaches, and weight loss in women. Headache 1997 37 (7) 433-436
65. Lampl C, Marecek S, May A, Bendtsen L. A prospective, open-label, long-term study of the efficacy and tolerability of topiramate in the prophylaxis of chronic tension-type headache. Cephalalgia 2006 26 (10) 1203-1208
66. Yurekli V A., Akhan G, Kutluhan S, Uzar E, Koyuncuoglu H R., Gultekin F. The effect of sodium valproate on chronic daily headache and its subgroups. J Headache Pain 2008 9 (1) 37-41
67. Fogelholm R, Murros K. Tizanidine in chronic tension-type headache: a placebo controlled double-blind cross-over study. Headache 1992 32 (10) 509-513
68. Murros K, Kataja M, Hedman C et al. Modified-release formulation of tizanidine in chronic tension-type headache. Headache 2000 40 (8) 633-637
69. Langemark M, Olesen J. Sulpiride and paroxetine in the treatment of chronic tension-type headache. An explanatory double-blind trial. Headache 1994 34 (1) 20-24 (Pubitemid 24038970)
70. Holroyd K A., Labus J S., O'Donnell F J., Cordingley G E. Treating chronic tension-type headache not responding to amitriptyline hydrochloride with paroxetine hydrochloride: a pilot evaluation. Headache 2003 43 (9) 999-1004
71. Adelman L C., Adelman J U., Von Seggern R, Mannix L K. Venlafaxine extended release (XR) for the prophylaxis of migraine and tension-type headache: A retrospective study in a clinical setting. Headache 2000 40 (7) 572-580
72. Mitsikostas D D., Gatzonis S, Thomas A, Ilias A. Buspirone vs amitriptyline in the treatment of chronic tension-type headache. Acta Neurol Scand 1997 96 (4) 247-251
73. Schulte-Mattler W J., Martinez-Castrillo J C. Botulinum toxin therapy of migraine and tension-type headache: comparing different botulinum toxin preparations. Eur J Neurol 2006 13 (Suppl 1) 51-54
74. Walker Z, Walker R W., Robertson M M., Stansfeld S. Antidepressant treatment of chronic tension-type headache: a comparison between fluoxetine and desipramine. Headache 1998 38 (7) 523-528
75. Sderberg E, Carlsson J, Stener-Victorin E. Chronic tension-type headache treated with acupuncture, physical training and relaxation training. Between-group differences. Cephalalgia 2006 26 (11) 1320-1329
76. Melis P M., Rooimans W, Spierings E L., Hoogduin C A. Treatment of chronic tension-type headache with hypnotherapy: a single-blind time controlled study. Headache 1991 31 (10) 686-689
77. Quinn C, Chandler C, Moraska A. Massage therapy and frequency of chronic tension headaches. Am J Public Health 2002 92 (10) 1657-1661
78. Bronfort G, Nilsson N, Haas M et al. Non-invasive physical treatments for chronic/recurrent headache. Cochrane Database Syst Rev 2004 (3) CD001878
79. Bigal M E., Rapoport A M., Sheftell F D., Tepper S J., Lipton R B. Transformed migraine and medication overuse in a tertiary headache centreclinical characteristics and treatment outcomes. Cephalalgia 2004 24 (6) 483-490
80. Mathew N T., Kurman R, Perez F. Drug induced refractory headacheclinical features and management. Headache 1990 30 (10) 634-638
81. Dodick D, Freitag F. Evidence-based understanding of medication-overuse headache: clinical implications. Headache 2006 46 (Suppl 4) S202-S211
82. Kavuk I, Katsarava Z, Selekler M et al. Clinical features and therapy of medication overuse headache. Eur J Med Res 2004 9 (12) 565-569
83. Smith T R., Stoneman J. Medication overuse headache from antimigraine therapy: clinical features, pathogenesis and management. Drugs 2004 64 (22) 2503-2514
84. Bigal M E., Serrano D, Buse D, Scher A, Stewart W F., Lipton R B. Acute migraine medications and evolution from episodic to chronic migraine: a longitudinal population-based study. Headache 2008 48 (8) 1157-1168
85. Bigal M E., Lipton R B. Excessive acute migraine medication use and migraine progression. Neurology 2008 71 (22) 1821-1828
86. Diener H C., Limmroth V. Medication-overuse headache: a worldwide problem. Lancet Neurol 2004 3 (8) 475-483
87. Lance F, Parkes C, Wilkinson M. Does analgesic abuse cause headaches de novo? Headache 1988 28 (1) 61-62
88. Ayzenberg I, Obermann M, Nyhuis P et al. Central sensitization of the trigeminal and somatic nociceptive systems in medication overuse headache mainly involves cerebral supraspinal structures. Cephalalgia 2006 26 (9) 1106-1114
89. Fumal A, Laureys S, Di Clemente L et al. Orbitofrontal cortex involvement in chronic analgesic-overuse headache evolving from episodic migraine. Brain 2006 129 (Pt 2) 543-550
90. Boes C J., Black D F., Dodick D W. Pathophysiology and management of transformed migraine and medication overuse headache. Semin Neurol 2006 26 (2) 232-241
91. Saper J R., Hamel R L., Lake A E. III. Medication overuse headache (MOH) is a biobehavioural disorder. Cephalalgia 2005 25 (7) 545-546
92. Fuh J L., Wang S J., Lu S R., Juang K D. Does medication overuse headache represent a behavior of dependence? Pain 2005 119 (1-3) 49-55
93. Zeeberg P, Olesen J, Jensen R. Discontinuation of medication overuse in headache patients: recovery of therapeutic responsiveness. Cephalalgia 2006 26 (10) 1192-1198
94. Rossi P, Di Lorenzo C, Faroni J, Cesarino F, Nappi G. Advice alone vs. structured detoxification programmes for medication overuse headache: a prospective, randomized, open-label trial in transformed migraine patients with low medical needs. Cephalalgia 2006 26 (9) 1097-1105
95. Obermann M, Katsarava Z. Management of medication-overuse headache. Expert Rev Neurother 2007 7 (9) 1145-1155
96. Be M G., Mygland A, Salvesen R. Prednisolone does not reduce withdrawal headache: a randomized, double-blind study. Neurology 2007 69 (1) 26-31
97. Diener H C. How to treat medication-overuse headache: prednisolone or no prednisolone? Neurology 2007 69 (1) 14-15
98. Mathew N T. Amelioration of ergotamine withdrawal symptoms with naproxen. Headache 1987 27 (3) 130-133
99. Krymchantowski A V., Barbosa J S. Prednisone as initial treatment of analgesic-induced daily headache. Cephalalgia 2000 20 (2) 107-113
100. Lu S R., Fuh J L., Juang K D., Wang S J. Repetitive intravenous prochlorperazine treatment of patients with refractory chronic daily headache. Headache 2000 40 (9) 724-729
101. Silberstein S D., Schulman E A., Hopkins M M. Repetitive intravenous DHE in the treatment of refractory headache. Headache 1990 30 (6) 334-339
102. Ford R G., Ford K T. Continuous intravenous dihydroergotamine in the treatment of intractable headache. Headache 1997 37 (3) 129-136
103. Schwartz T H., Karpitskiy V V., Sohn R S. Intravenous valproate sodium in the treatment of daily headache. Headache 2002 42 (6) 519-522
104. Katsarava Z, Jensen R. Medication-overuse headache: where are we now? Curr Opin Neurol 2007 20 (3) 326-330
105. Katsarava Z, Muessig M, Dzagnidze A, Fritsche G, Diener H C., Limmroth V. Medication overuse headache: rates and predictors for relapse in a 4-year prospective study. Cephalalgia 2005 25 (1) 12-15
106. Garza I, Swanson J W. Answers to frequently asked questions about migraine. Mayo Clin Proc 2006 81 (10) 1387-1391, quiz 1392
107. Rozen T D. New daily persistent headache. Curr Pain Headache Rep 2003 7 (3) 218-223
108. Vanast W J. New daily persistent headaches definition of a benign syndrome. Headache 1986 26 317-320 (Abstract)
109. Takase Y, Nakano M, Tatsumi C, Matsuyama T. Clinical features, effectiveness of drug-based treatment, and prognosis of new daily persistent headache (NDPH): 30 cases in Japan. Cephalalgia 2004 24 (11) 955-959
110. Li D, Rozen T D. The clinical characteristics of new daily persistent headache. Cephalalgia 2002 22 (1) 66-69
111. Bigal M E., Sheftell F D., Rapoport A M., Lipton R B., Tepper S J. Chronic daily headache in a tertiary care population: correlation between the International Headache Society diagnostic criteria and proposed revisions of criteria for chronic daily headache. Cephalalgia 2002 22 (6) 432-438
112. Diaz-Mitoma F, Vanast W J., Tyrrell D L. Increased frequency of Epstein-Barr virus excretion in patients with new daily persistent headaches. Lancet 1987 1 (8530) 411-415
113. Hamada T, Ohshima K, Ide Y, Sakato S, Takamori M. A case of new daily persistent headache with elevated antibodies to Epstein-Barr virus. Jpn J Med 1991 30 (2) 161-163
114. Meineri P, Torre E, Rota E, Grasso E. New daily persistent headache: clinical and serological characteristics in a retrospective study. Neurol Sci 2004 25 (Suppl 3) S281-S282
115. Santoni J R., Santoni-Williams C J. Headache and painful lymphadenopathy in extracranial or systemic infection: etiology of new daily persistent headaches. Intern Med 1993 32 (7) 530-532
116. Rozen T D. New daily persistent headache In: Goadsby PJ, Dodick DW Chronic Daily Headache for Clinicians. 1st Ed. Hamilton, Ontario BC Decker Inc. 2005 209-215
117. Goadsby P J., Boes C. New daily persistent headache. J Neurol Neurosurg Psychiatry 2002 72 (Suppl 2) ii6-ii9
118. Rossi P, Faroni J, Tassorelli C, Nappi G. Diagnostic delay and suboptimal management in a referral population with hemicrania continua. Headache 2009 49 (2) 227-234
119. Peres M F., Silberstein S D., Nahmias S et al. Hemicrania continua is not that rare. Neurology 2001 57 (6) 948-951
120. Dodick D. Hemicrania continua: diagnostic criteria and nosologic status. Cephalalgia 2001 21 (9) 869-872
121. Matharu M S., Cohen A S., McGonigle D J., Ward N, Frackowiak R S., Goadsby P J. Posterior hypothalamic and brainstem activation in hemicrania continua. Headache 2004 44 (8) 747-761
122. Irimia P, Arbizu J, Prieto E, Fernndez-Torrn R, Martnez-Vila E. Activation of the brainstem but not of the hypothalamus in hemicrania continua without autonomic symptoms. Cephalalgia 2009 29 (9) 974-979
123. Matharu M S., Boes C J., Goadsby P J. Management of trigeminal autonomic cephalgias and hemicrania continua. Drugs 2003 63 (16) 1637-1677
124. Marmura M J., Silberstein S D., Gupta M. Hemicrania continua: who responds to indomethacin? Cephalalgia 2009 29 (3) 300-307
125. Bigal M E., Tepper S J., Rapoport A M., Sheftell F D. Hemicrania continua: comparison between two different classification systems. Cephalalgia 2002 22 (3) 242-245
126. Eross E J., Swanson J W., Dodick D W. Hemicrania continua: an indomethacin-responsive case with an underlying malignant etiology. Headache 2002 42 (6) 527-529
127. Antonaci F, Sjaastad O. Hemicrania continua: a possible symptomatic case, due to mesenchymal tumor. Funct Neurol 1992 7 (6) 471-474
128. Valena M M., Andrade-Valena L P., da Silva W F., Dodick D W. Hemicrania continua secondary to an ipsilateral brainstem lesion. Headache 2007 47 (3) 438-441
129. Rogalewski A, Evers S. Symptomatic hemicrania continua after internal carotid artery dissection. Headache 2005 45 (2) 167-169
130. Peres M F., Zukerman E, Porto P P., Brandt R A. Headaches and pineal cyst: a (more than) coincidental relationship? Headache 2004 44 (9) 929-930
131. Levy M J., Matharu M S., Meeran K, Powell M, Goadsby P J. The clinical characteristics of headache in patients with pituitary tumours. Brain 2005 128 (Pt 8) 1921-1930
132. Pareja J, Sjaastad O. Chronic paroxysmal hemicrania and hemicrania continua. Interval between indomethacin administration and response. Headache 1996 36 (1) 20-23
133. Pareja J A., Caminero A B., Franco E, Casado J L., Pascual J, Snchez del Ro M. Dose, efficacy and tolerability of long-term indomethacin treatment of chronic paroxysmal hemicrania and hemicrania continua. Cephalalgia 2001 21 (9) 906-910
134. Rozen T D. Melatonin responsive hemicrania continua. Headache 2006 46 (7) 1203-1204
135. Peres M F., Silberstein S D. Hemicrania continua responds to cyclooxygenase-2 inhibitors. Headache 2002 42 (6) 530-531
136. Schwedt T J., Dodick D W., Hentz J, Trentman T L., Zimmerman R S. Occipital nerve stimulation for chronic headachelong-term safety and efficacy. Cephalalgia 2007 27 (2) 153-157
137. Camarda C, Camarda R, Monastero R. Chronic paroxysmal hemicrania and hemicrania continua responding to topiramate: two case reports. Clin Neurol Neurosurg 2008 110 (1) 88-91
138. Burns B, Watkins L, Goadsby P J. Treatment of hemicrania continua by occipital nerve stimulation with a bion device: long-term follow-up of a crossover study. Lancet Neurol 2008 7 (11) 1001-1012
139. Garza I, Cutrer F. Pain relief and persistence of dysantonomic features in a patient with hemicrania continua responsive to botulinum toxin type A. Cephalalgia 2009 June 10 (Epub ahead of print)